Alexion Pharmaceuticals, Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (34)

Latest Posts

About This Stock More About This Stock
3 ETFs To Watch On Biotech Earnings
Article By: Zacks Investment Research
Sunday, October 29, 2017 5:13 PM EST
The earnings season is off to a flying start with equity markets. However, the performance has been a mixed bag for biotech companies with some beating market expectations, while a few failed to do so.
In this article: ALXN, AMGN, BIIB, BIB, IBB, BBH, GILD
Read
3 Biotech And Pharma Stocks With Key FDA Catalysts This October
Article By: Arpita Dutt
Monday, October 2, 2017 10:16 AM EST
The FDA, which approved 22 novel drugs last year, has given its approval to 34 drugs so far in 2017 including three in September.
In this article: FLXN, ALXN, PTCT Also: JNJ, TSRO, ACRX, AERI
Read
Here Are 5 Robust Stocks That Can Weather A Downturn
Article By: TipRanks
Sunday, October 1, 2017 9:57 AM EST
Payment processing giant Mastercard is one of the strongest payment companies out there. As the world increasingly moves away from cash and towards digital payments, MA stands to reap the rewards.
In this article: MA, ALXN, CELG, IDXX, BABA
Read
Alexion: Canada's Drug Price Watchdog Ordered Price Cut For Soliris
Article By: Shock Exchange
Saturday, September 30, 2017 7:55 PM EST
Canada's drug price watchdog ordered ALXN to cut prices for Soliris. A potential revenue slow down in the second half of 2017 implies growth is dead. Price cuts in Canada could hasten ALXN's slow down and cause negative sentiment for the stock.
In this article: ALXN
Read
5 Top-Ranked Biotech Stocks To Buy Right Now
Article By: Arpita Dutt
Monday, September 11, 2017 1:09 PM EST
Picking biotech stocks can be a bit tricky given the “high risk - high returns” nature of the industry. Moreover, the estimate revision trend for the sector is not very encouraging.
In this article: REGN, ALXN, LGND, SGMO, FATE Also: KITE, GILD
Read

PARTNER HEADLINES

Latest Tweets for $ALXN

No tweets yet!